David J. Gallacher
Johnson & Johnson (United States)(US)Janssen (Belgium)(BE)
Publications by Year
Research Areas
Cardiac electrophysiology and arrhythmias, Ion channel regulation and function, Anesthesia and Sedative Agents, Pluripotent Stem Cells Research, Receptor Mechanisms and Signaling
Most-Cited Works
- → Experimentally calibrated population of models predicts and explains intersubject variability in cardiac cellular electrophysiology(2013)327 cited
- → High throughput measurement of Ca2+ dynamics for drug risk assessment in human stem cell-derived cardiomyocytes by kinetic image cytometry(2012)129 cited
- → The Concordance between Nonclinical and Phase I Clinical Cardiovascular Assessment from a Cross-Company Data Sharing Initiative(2014)75 cited
- → Calmodulin Antagonist W‐7 Prevents Sparfloxacin‐Induced Early Afterdepolarizations (EADs) in Isolated Rabbit Purkinje Fibers: Importance of Beat‐to‐Beat Instability of the Repolarization(2006)26 cited
- → Both β-adrenergic receptor stimulation and cardiac tissue type have important roles in elucidating the functional effects of IKs channel blockers in vitro(2004)24 cited
- → Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?(2012)19 cited
- → Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)(2023)15 cited
- → Effect of sitagliptin treatment on metabolism and cardiac function in genetic diabetic mice(2014)14 cited
- → Identifying Acute Cardiac Hazard in Early Drug Discovery Using a Calcium Transient High-Throughput Assay in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes(2022)8 cited
- → Prothrombotic effect of Rofecoxib in a murine venous thrombosis model(2008)7 cited